Investview Reports Sharp Revenue Decline, Discontinues Crypto Operations — Investview, Inc.

Event summary

Q2 2026 revenue plummeted 73.2% YoY to $2.6M, with net loss widening to $2.1M from prior-year profit of $0.4M.
Company sold $8.3M stake in nuclear-tech investment post-quarter, netting ~$7.05M gain before adjustments.
Discontinued blockchain/crypto mining segment in July 2026 to streamline portfolio.
Conectiv revenue dropped 73.3% due to European network contraction following Polish regulator UOKiK decision.
Opencash brokerage platform launch delayed to Q2 2027 amid tech/compliance gaps.

The big picture

Investview's sharp revenue decline reflects broader challenges in direct-to-consumer marketing platforms and regulatory pressures in key geographies. The company's strategic pivot toward integrated membership offerings and delayed commercialization of Opencash highlight the tension between portfolio simplification and the need for scalable growth. With $8.3M in liquidity from its nuclear-tech investment sale, Investview has breathing room—but its ability to execute on core business turnarounds remains the critical variable.

What we're watching

Execution Risk: Whether Investview can stabilize Conectiv's European operations amid regulatory headwinds and distributor network contraction.
Capital Efficiency: The pace at which the company can transition from cash-burning pre-commercial phases to revenue-generating operations across its core segments.
Strategic Focus: How the integration of Conectiv, MyLife Wellness, and Renu Laboratories will impact operational synergies and margin profiles.